# Targeting Psychosis in Alzheimer’s Disease

Page: https://stenobird.com/podcast/the-bio-report-1092382/targeting-psychosis-in-alzheimer-s-disease
Text version: https://stenobird.com/podcast/the-bio-report-1092382/targeting-psychosis-in-alzheimer-s-disease.md
Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382)
Published: 2026-04-01T07:00:00+00:00
Episode link: https://thebioreport.podbean.com/e/targeting-psychosis-in-alzheimer-s-disease/
Audio file: https://mcdn.podbean.com/mf/web/ckvieq537szaukms/BR-Elizabeth_Thompson-4-1-26b6tsj.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/targeting-psychosis-in-alzheimer-s-disease
Duration seconds: 1329

## Resource

Alzheimer’s disease drug development has long focused on slowing memory loss, but for many families, the tipping point that makes home care impossible is not cognition—it is psychosis. Hallucinations and delusions in Alzheimer’s are a distinct, prevalent, and under-recognized target for therapy. We spoke to Elizabeth Thompson, executive vice president and head of R&D at Acadia Pharmaceuticals, about the biology behind psychosis in dementia, the company’s experimental therapy to treat the condition in people with Alzheimer’s disease, and the forces reshaping the drug development landscape to enable the development of such treatments.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/targeting-psychosis-in-alzheimer-s-disease/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/targeting-psychosis-in-alzheimer-s-disease.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.